Víctor Aarón Aarón Álvarez-Sánchez

Dr. Víctor Aarón Aarón Álvarez-Sánchez

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2019 in Educación Médica
Verified
Journal Article
Open access
PDF file
VÁVíctor Aarón Aarón Álvarez-Sánchez
Víctor Aarón Aarón Álvarez-Sánchez
MSMoisés de Los Santos-Rodriguez
Moisés de Los Santos-Rodriguez
EGEddgar García-Santamaría
Eddgar García-Santamaría
Introducción: Ante la creciente demanda de atención neurológica y la importancia de la exploración neurológica para el diagnóstico, se propone una intervención educativa basada en simulación (IEBS) para el desarrollo de la competencia clínica en exploración neurológica (CCEN). Métodos: Estudio cuasiexperimental con 34 estudiantes de segundo año de Medicina, seleccionados mediante muestreo no probabilístico, excluyendo aquellos que tuvieran algún curso en neurología. Todos recibieron la IEBS, la cual consistió en una sesión de 60 minutos con un experto en neurología, 2 sesiones prácticas de 30 minutos cada una con un paciente estandarizado y posterior retroalimentación y una sesión general de retroalimentación de 60 minutos. Todos los participantes fueron evaluados antes y después de la IEBS utilizando la rúbrica de habilidades clínicas básicas en neurología (HCBN) que considera 9 aspectos de la exploración neurológica. Resultados: Ningún participante contaba con la CCEN antes de la IEBS y 9 la desarrollaron posteriormente. Utilizando la prueba de McNemar, la diferencia en la CCEN entre los grupos pretest y postest fue estadísticamente significativa (0% vs. 26,47%, p = 0,004). De los 9 apartados de la rúbrica, 8 mostraron una mejora significativa (p < 0,05). La relación médico-paciente fue la única que no mostró significación estadística; no obstante, tuvo mejoría (88,2% vs, 100%, p = 0,125). Conclusión: La IEBS se relacionó con un aumento significativo en la CCEN tanto de manera global como en cada apartado de la misma, por lo que se recomienda su uso ya que la consideramos una herramienta útil para mejorar el desempeño de los estudiantes en exploración neurológica.’ Introduction: Given the growing demand for neurological care and the importance of the neurological examination for diagnosis, an Educational Intervention Based on Simulation (IEBS) is proposed for the development of Clinical Competence in Neurological Examination (CCEN). Methods: A quasi-experimental study was performed with 34 second-year medical students, selected with non-probabilistic sampling, and excluding those who have had any course in neurology. All received the IEBS, which consisted of a 60-minute session with a neurology expert, 2 hands-on 30 minutes’ sessions with a Standardized Patient and feedback and a general 60-minute feedback. All participants were evaluated before and after the IEBS using the basic clinical skills in neurology rubric (HCBN) that considers 9 aspects of neurological examination. Results: No participant had the CCEN prior to the IEBS, and 9 developed it afterwards. Using the McNemar test, the difference in the CCEN between the Pre-test and Post-test groups was statistically significant (0% vs 26.47%, P = .004). Of the 9 sections of the rubric, 8 improved significantly (P < .05). The physician-patient relationship was the only one that did not show statistical significance, however, it did show improvement (88.2% vs. 100%, P = .125). Conclusion: The IEBS is related to a significant increase in the overall CCEN, as well as in each section of it. Thus the IEBS is considered to be useful to improve the performance of students in neurology examinations, for which its use is recommended.

1 April 2024 in Heliyon
Verified
Journal Article
Open access
VÁVíctor Aarón Aarón Álvarez-Sánchez
Víctor Aarón Aarón Álvarez-Sánchez
MSMaría Alejandra Salcedo-Parra
María Alejandra Salcedo-Parra
GBGustavo Bonnabel-Becerra
Gustavo Bonnabel-Becerra
ACArturo Cortes-Telles
Arturo Cortes-Telles
Social determinants have played a role in COVID-19 outcomes and vaccination has improved these and impacted on inflammatory response, we therefore sought to investigate the association between vaccination and inflammatory response with COVID-19 mortality in a Mexican population with high marginalization during the Omicron wave. Prospective, longitudinal, single-center study in a setting of high marginalization conducted during the Omicron wave, from January to November 2022. Clinical and laboratory data were collected during admission and patients were followed until discharge or death. Patients were grouped according to outcome (survival and non-survival), and by complete (2 or more doses) and incomplete vaccination status for comparison. 118 patients were included, 54% (64/118) male, with a median age 63 years and 86% (102/118) with self-reported comorbidities. Mortality was 42%. 58% (68/118) had complete vaccination. There was a 64% risk reduction for all-cause in-hospital mortality of having complete vaccination, hazard ratio 0.36, (95% CI 0.18–0.71, p = 0.004) in the proportional hazards Cox regression test. Survivor group arrived earlier to medical care and had higher SpO2 on admission, and for inflammatory response, had lower levels of Neutrophil-to-lymphocyte ratio, C-reactive protein, and D-dimer at admission. In the longitudinal measurement, only D-dimer showed significant differences between groups according to survival. In a highly marginalized Mexican population, complete vaccination has a protective effect against COVID-19 all-cause in-hospital mortality compared with incomplete or no vaccination. However, mortality in this population during the Omicron wave is high. Socio-economic inequalities may play an important role in COVID-19 outcomes.

10 January 2024 in Cureus
Verified
Journal Article
Open access
FPFelipe de Jesus Perez-Hernandez
Felipe de Jesus Perez-Hernandez
VÁVíctor Aarón Aarón Álvarez-Sánchez
Víctor Aarón Aarón Álvarez-Sánchez
DTDarwin Torres-Erazo
Darwin Torres-Erazo
MCMonica Ceballos-Perez
Monica Ceballos-Perez
CFCarlos David Franco-Gonzalez
Carlos David Franco-Gonzalez
Mpox (monkeypox) is a zoonotic disease that has been endemic in African countries for decades, with a recent global outbreak in countries around the world. A 39-year-old male with human immunodeficiency virus (HIV)-hepatitis B virus (HBV) coinfection and poor adherence to antiretroviral treatment, who was severely immunocompromised and had a concurrent diagnosis of Mpox, presented to our hospital with disseminated skin lesions (over 350 lesions), perianal ulcers, odynophagia, oral intolerance, diarrhea, and soft-tissue bacterial superinfection of the lower extremities. Laboratory results were consistent with HBV infection, with an absolute CD4 cell count of 40 cells/uL and a positive PCR result for monkeypox virus. An abdominopelvic CT scan showed evidence of severe proctitis and perineal soft-tissue infection. Sixty-five days after a positive monkeypox virus PCR, new lesions in the vesicular stage continued to appear, eventually developing hemodynamic instability and sepsis, resulting in a fatal outcome. Our case highlights the importance of intentionally looking for risk factors such as HIV/HBV coinfection and evaluating immune status (CD4 cell count) in patients with severe Mpox because it could be related to higher mortality.

28 February 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
FHFELIPE DE JESUS PEREZ HERNANDEZ
FELIPE DE JESUS PEREZ HERNANDEZ
VÁVíctor Aarón Aarón Álvarez-Sánchez
Víctor Aarón Aarón Álvarez-Sánchez
DTDarwin Stalin Torres-Erazo
Darwin Stalin Torres-Erazo
RHRober Ambriz Huerta
Rober Ambriz Huerta
MPMonica Ceballos Perez
Monica Ceballos Perez
CGCarlos David Franco González
Carlos David Franco González
Mpox (monkeypox) is a zoonotic disease that has been endemic in African countries for decades, with a recent outbreak in several countries around the world. A 39-year-old male with HIV-HBV coinfection and poor adherence to antiretroviral treatment, who was severely immunocompromised and had a concurrent diagnosis of Mpox infection, presented to our hospital with disseminated dermatosis (over 350 lesions), perianal ulcers, odynophagia, oral intolerance, diarrhea, and soft-tissue bacterial superinfection of the lower extremities. Laboratory results were consistent with HBV infection, with an absolute CD4 cell count of 40 cells/uL and a positive PCR result for Mpox. An abdominopelvic CT scan showed evidence of severe proctitis and perineal soft-tissue infection. After 65 days of Mpox PCR, new lesions in the vesicular stage continued to appear, eventually developing hemodynamic instability and sepsis, resulting in a fatal outcome. Our case highlights the importance of intentionally looking for risk factors such as HIV/HBV coinfection and evaluating immune status (CD4 cell count) in patients with severe Mpox infection because it could be related to higher mortality.

9 September 2023 in European Respiratory Journal
Verified
Conference Paper
Closed access
VÁVíctor Aarón Aarón Álvarez-Sánchez
Víctor Aarón Aarón Álvarez-Sánchez
ACArturo Cortes-Telles
Arturo Cortes-Telles
MSM. Alejandra Salcedo-Parra
M. Alejandra Salcedo-Parra
GBGustavo Bonnabel-Becerra
Gustavo Bonnabel-Becerra
Introduction: An overall milder disease and lower mortality is reported in the Omicron SARS-CoV-2 variant (OV). Since vaccination, outcomes due to severe COVID-19 have changed. Outcomes in Hispanic population have consistently showed higher mortality, however data during Omicron wave (OW) in Mexico is lacking. Aims and Objectives: To identify the relation of vaccination status with outcomes among Mexican patients hospitalized with severe COVID-19 during the OW. Methods: We prospectively collected data from all admitted patients with severe COVID-19 where the OV represented more than 75% of the sequenced samples. Comparisons were made according to survival status. A multivariate logistic regression analysis was performed to identify factors related with mortality. Results: 118 patients were included, 54% were male, median age of 63 years (IQR 27), 86% of patients with self-reported morbidities (hypertension 40%) and 42% died. 53% of non-survivors had <1 vaccine dose. On admission, non-survivors showed lower SpO2/FiO2 ratio (184 vs 375, p=0.004) and higher qSOFA (2 vs 1, p=0.01), Neutrophil-to-lymphocyte ratio (12 vs 9, p=0.01), C-reactive protein (148 vs 83, p=0.009), and D-dimer (2546 vs 1640, p=0.004). The need of mechanical ventilation (OR 33.3, 95% CI 8.4-127.8, p2 doses (OR 0.32, 95% CI 0.13-0.83, p=0.019) were the main risk factors for mortality during OW. Conclusions: In Mexican patients hospitalized with severe COVID-19 during the OW, vaccination (>2 doses) reduced 68% the risk of death. Other routine biomarkers showed a significant association with mortality as has been reported in previous waves.